Evidence-based clinical practice guidelines for liver cirrhosis 2015 Hiroshi FukuiHidetsugu SaitoTooru Shimosegawa Special Article 31 May 2016 Pages: 629 - 650
PKD signaling and pancreatitis Jingzhen YuanStephen J. Pandol Review 15 February 2016 Pages: 651 - 659
Gut microbiome diversity in acute infective and chronic inflammatory gastrointestinal diseases in North India Saurabh KediaRitika RampalVineet Ahuja Review 19 March 2016 Pages: 660 - 671
Genetic characteristics of inflammatory bowel disease in a Japanese population Yuta FuyunoKeiko YamazakiMichiaki Kubo Original Article—Alimentary Tract 28 October 2015 Pages: 672 - 681
Detection of palisade vessels as a landmark for Barrett’s esophagus in a Western population Dirk W. SchölvinckOsamu GotoBas L. A. M. Weusten Original Article—Alimentary Tract 04 November 2015 Pages: 682 - 690
Aspirin-induced gastrointestinal damage is associated with an inhibition of epithelial cell autophagy Carlos HernándezMaria Dolores BarrachinaSara Calatayud Original Article—Alimentary Tract 03 November 2015 Pages: 691 - 701
Long-term outcomes after treatment for pedunculated-type T1 colorectal carcinoma: a multicenter retrospective cohort study Naoki AsayamaShiro OkaKazuaki Chayama Original Article—Alimentary Tract 16 November 2015 Pages: 702 - 710
A potent therapeutics for gallbladder cancer by combinatorial inhibition of the MAPK and mTOR signaling networks Dai MohriHideaki IjichiKazuhiko Koike Original Article—Liver, Pancreas, and Biliary Tract 27 November 2015 Pages: 711 - 721
Distinguished prognosis after hepatectomy of HBV-related hepatocellular carcinoma with or without cirrhosis: a long-term follow-up analysis Sheng-li YangLi-ping LiuPaul B. S. Lai Original Article—Liver, Pancreas, and Biliary Tract 25 November 2015 Pages: 722 - 732
Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C Goki SudaMineo KudoNaoya Sakamoto Original Article—Liver, Pancreas, and Biliary Tract 14 January 2016 Pages: 733 - 740
Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis Hidenori ToyodaTakashi KumadaYasuhito Tanaka Original Article—Liver, Pancreas, and Biliary Tract 12 February 2016 Pages: 741 - 747
Changing Nomenclature for PBC from “Primary Biliary Cirrhosis” to “Primary Biliary Cholangitis” Atsushi TanakaHajime TakikawaToru Shimosegawa Editorial 26 May 2016 Pages: 748 - 749
Erratum to: Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis Hidenori ToyodaTakashi KumadaYasuhito Tanaka Erratum 07 March 2016 Pages: 750 - 750